BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18207660)

  • 1. (106)Ruthenium brachytherapy for retinoblastoma.
    Abouzeid H; Moeckli R; Gaillard MC; Beck-Popovic M; Pica A; Zografos L; Balmer A; Pampallona S; Munier FL
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):821-8. PubMed ID: 18207660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-ray brachytherapy with 106Ru plaques for retinoblastoma.
    Schueler AO; Flühs D; Anastassiou G; Jurklies C; Neuhäuser M; Schilling H; Bornfeld N; Sauerwein W
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1212-21. PubMed ID: 16682139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹⁰⁶Ruthenium plaque therapy (RPT) for retinoblastoma.
    Murakami N; Suzuki S; Ito Y; Yoshimura R; Inaba K; Kuroda Y; Morota M; Mayahara H; Sakudo M; Wakita A; Okamoto H; Sumi M; Kagami Y; Nakagawa K; Ohtomo K; Itami J
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):59-65. PubMed ID: 22575488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.
    Anastassiou G; Bornfeld N; Schueler AO; Schilling H; Weber S; Fluehs D; Jurklies B; Vij O; Sauerwein W
    Br J Ophthalmol; 2006 Apr; 90(4):447-50. PubMed ID: 16547325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma.
    Kreusel KM; Bornfeld N; Lommatzsch A; Wessing A; Foerster MH
    Ophthalmology; 1998 Aug; 105(8):1386-92. PubMed ID: 9709747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of ruthenuim 106 in retinoblastoma treatment].
    Pochop P; Malis J; Símová B; Malec J; Palkosková P
    Cesk Slov Oftalmol; 2005 May; 61(3):192-7. PubMed ID: 15984081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque.
    Schueler AO; Flühs D; Anastassiou G; Jurklies C; Sauerwein W; Bornfeld N
    Ophthalmic Res; 2006; 38(1):8-12. PubMed ID: 16166817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy in the treatment of retinoblastoma: about 40 cases].
    Frikha H; Chaari N; Nasr C; Bouguila H; Chebbi A; Bhouri L; Hentati D; Kochbati L; Besbes M; Rifi H; Oubiche F; Ayed S; Maalej M
    Cancer Radiother; 2009 Jan; 13(1):30-6. PubMed ID: 18790660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy in the management of retinoblastoma.
    Kiratli H; Bilgiç S; Atahan IL
    Turk J Pediatr; 1998; 40(3):393-7. PubMed ID: 9763903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local tumor control after 106Ru brachytherapy of choroidal melanoma.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):385-91. PubMed ID: 15913907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
    Abramson DH; Schefler AC
    Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
    Chan MP; Hungerford JL; Kingston JE; Plowman PN
    Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.
    Abramson DH; Frank CM
    Ophthalmology; 1998 Apr; 105(4):573-9; discussion 579-80. PubMed ID: 9544627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
    Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
    Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
    Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
    Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.